ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
hace 258
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
hace 629
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
hace 956
TSX Tumbles More Than 1% As Stocks Fall On Tariff Concerns
After posting a record close the previous day, the Canadian market opened marginally up and edged higher Friday morning, but kept losing ground as the day progressed with stocks from across several sectors reeling under selling pressure as Trump administration confirmed that it would begin imposing 25% tariffs on imports from Canada from February 1.
RTTNews
|
hace 1
German Inflation Unexpectedly Eases In January
Consumer price pressures in Germany slowed unexpected at the start of the year amid a sharp slowdown in food inflation, offering some relief for the European Central Bank that lowered interest rates a day earlier and plan to continue easing to boost the single currency economy that came to a standstill in the final three months of 2024.
RTTNews
|
hace 1
Swiss Markets Ends Slightly Weak
The Swiss market edged down marginally on Friday with stocks paring gains in late afternoon trade as investors chose to take some profits following a long winning streak. Data showing a stronger than expected jump in the nation's retail sales aided sentiment.
RTTNews
|
hace 1
Major European Markets Close Slightly Higher
European stocks saw some profit taking in late afternoon trades on Friday, but the major markets in the region still managed to close slightly up.
Investors assessed recent economic data, earnings news, and monetary policy announcements of the Federal Reserve and the European Central Bank.
RTTNews
|
hace 1
Canadian Market Down Marginally In Cautious Trade; Tech Stocks Move Higher
The Canadian market is up in positive territory a little past noon on Friday with the benchmark S&P/TSX Composite Index hovering near record high, thanks largely to strong buying in the technology sector after encouraging earnings updates from big name U.S. companies such as Apple Inc. and Meta Platforms.
RTTNews
|
hace 2
